Investors Can Sue Procept BioRobotics Over Securities Fraud Claims
LOS ANGELES, Sept. 1, 2026 /CourierPR/ -- Investors who suffered financial losses due to their investments in Procept BioRobotics Corporation now have an opportunity to lead a securities fraud lawsuit against the company, according to a legal notice issued by Glancy Prongay Wolke & Rotter LLP.
Between February 28, 2024, and February 25, 2026, the lawsuit alleges that Procept BioRobotics Corporation and its executives made materially false and misleading statements regarding the company’s business, operations, and financial condition. The complaint specifically claims that Procept used an extensive discount program to incentivize customers to place bulk handpiece orders, which were often in excess of the actual procedure demand. This program, which was not disclosed to investors, artificially and unsustainably inflated the company’s reported U.S. handpiece unit sales and revenues by pulling forward sales into the current period at the expense of future periods.
According to the lawsuit, the discount program caused customer handpiece orders to significantly exceed underlying procedure demand, and this differential increased over time. The company’s surplus of U.S. handpiece sales relative to procedures created an excess field inventory and overstocking among its customers, with more than 10,000 excess units by the end of the class period. The lawsuit further alleges that as a result, Procept’s statements about its business, operations, and prospects were materially misleading and lacked a reasonable basis.
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, is urging investors who suffered losses to act quickly. To participate in the lawsuit, investors must file a motion to serve as lead plaintiff with the court no later than September 22, 2026. The firm offers free initial consultations to help investors understand their rights and options.
“Procept BioRobotics Corporation’s misleading statements and practices significantly harmed investors,” said Charles Linehan, a partner at Glancy Prongay Wolke & Rotter LLP. “We are committed to representing our clients and ensuring they have the opportunity to seek justice for their losses.”
Glancy Prongay Wolke & Rotter LLP has extensive experience in securities litigation and has been recognized for its success in representing investors. The firm has been named one of Law360’s Securities Groups of the Year and ranked second in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025. Its lawyers have handled cases across various sectors and have been featured in leading publications such as The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron’s, Investor’s Business Daily, Forbes, and Money.
No class has yet been certified, and investors are advised to act promptly to preserve their rights.